Emerging therapies for respiratory diseases.
This Society for Medicines Research symposium, sponsored by UCB, was held on September 11, 2007, at the Wellcome Trust Conference Centre, Hinxton, Cambridge, United Kingdom. The meeting, organized by Ruth Lock, Steve Collingwood and Andrew Ratcliffe, reviewed current thinking in the area of airway drug delivery and the challenges and progress made in the discovery and development of novel medicines to treat respiratory diseases, such as chronic obstructive pulmonary disease, asthma, allergic rhinitis and cystic fibrosis.
Lock
Ruth
R
Society for Medicines Research Committee, UK.
Collingwood
Steve
S
Ratcliffe
Andrew
A
D000085:Acetates / Q000737:chemistry / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use; D000069502:Budesonide, Formoterol Fumarate Drug Combination; D003521:Cyclopropanes; D004338:Drug Combinations; D004358:Drug Therapy / Q000379:methods* / Q000639:trends; D004983:Ethanolamines / Q000627:therapeutic use; D006801:Humans; D020024:Leukotriene Antagonists / Q000737:chemistry / Q000627:therapeutic use; D015394:Molecular Structure; D011804:Quinolines / Q000737:chemistry / Q000627:therapeutic use; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013440:Sulfides
D000085:Acetates; D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000069502:Budesonide, Formoterol Fumarate Drug Combination; D003521:Cyclopropanes; D004338:Drug Combinations; D004983:Ethanolamines; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D019819:Budesonide; C093875:montelukast; D000420:Albuterol